Authors



Arthur Wang

Latest:

Cloud Computing: Security in Clinical Trials

There is a lot of buzz about “the cloud.” Formally known as cloud computing, the cloud relies on sharing of Information Technology (IT) resources.


Wendy Tate

Latest:

A Critical Piece of the Research Puzzle: How Metrics Have Transformed Clinical Trials

Three key insights about clinical trial advancements made possible by the advent of metrics


Adrian Wildfire

Latest:

Human Challenge Studies in Early Phase Antiviral Development

The concept of the human challenge model (HCM) originated from early societal attempts to halt the spread of acute diseases within their own communities


Jonathan Rowe, PhD, MS, MA

Latest:

The Eradication of False Signals in Monitoring

How optimizing RBQM risk detection reduces the efforts caused by false signals.


Lori McKellar

Latest:

Targeting eTMF for Efficiency and Productivity Gains

In clinical trials, the ability to effectively plan, collect and maintain essential clinical trial documentation is challenging.


Paul Donnelly

Latest:

Expanding Data Management Services in China

EDC has become the data management platform of choice around the world, offering advantages such as increasing the quality and timely collection of data. Medrio, an EDC company that offers eClinical software solutions, has quoted that 70% of clinical trials are using EDC as a forms of collecting data in the United States. In China, we have seen adoption rates for EDC increase dramatically in recent years, fuelled by improved technology developments in mobile applications, and the increasing experience with EDC usage in clinical research.


Craig Morgan

Latest:

Millennials and their Impact on Clinical Research

The importance of examining this generation’s influence on the clinical trial value chain.


Katherine Ni

Latest:

The Employee Profile in China Pharma R&D

In this analysis, distinctions between who hires who in non-Chinese and China-based companies emerges.


Mathini Ilancheran

Latest:

Impact of Actigraphy in Clinical Research

With all the buzz around wearables, actigraphs-which monitor sleep and daytime activity levels-have been around for decades.


Juanjo Cardona

Latest:

The Employee Profile in China Pharma R&D

In this analysis, distinctions between who hires who in non-Chinese and China-based companies emerges.


Denise Calaprice-Whitty

Latest:

Bridging the Gap for Better Patient Engagement

A survey from the Avoca Group examines issues related to quality of clinical trials and trial participation from the patients' view.


Jeffry Liu

Latest:

Considerations for Clinical Trial Design in Public Health Emergencies

While the fundamental concerns behind the design of most modern clinical trials are effectively the same, clinical trials that take place during public health emergencies face additional layers of challenges.



Elizabeth Dalton

Latest:

Five Steps to Increase Site Satisfaction and Study Success

Over the past three decades, clinical imaging has become an integral part of the drug development process for biopharmaceutical companies.



PAREXEL

Latest:

FSP Partnership: A Foundation for Innovation and Patient-Guided Development

Liz Rogers, VP and Head of Global Site and Study Operations at Pfizer, discusses Pfizer's partnership with Parexel and transition to a functional service provider (FSP) model.


Murray A. Abramson, MD

Latest:

Outsourcing Strategies and Practices to Improve Efficiency and Performance

Demand for outsourced services to provide clinical development capacity and expertise has grown substantially over the last 10 years.


Frances Grote

Latest:

Outsourcing Strategies and Practices to Improve Efficiency and Performance

Demand for outsourced services to provide clinical development capacity and expertise has grown substantially over the last 10 years.


Bernadette Tosti

Latest:

Improving Minority Recruitment in Clinical Trials

Promising new approaches to optimize data and outcomes.


Grant Dietrich

Latest:

Focus on the Patient: The Digital Evolution of IRT

Cenduit has benefited greatly from the relationship we have with our parent companies, from Quintiles’ clinical development experience to Thermo Fisher Scientific’s clinical supply chain know-how.


Lisa Carlson

Latest:

Death Waivers an Incomplete Picture of Drug Safety

Examining the practical significance of reporting patient deaths due to main disease progression.


Nickolai Usachev, MD

Latest:

Death Waivers an Incomplete Picture of Drug Safety

Examining the practical significance of reporting patient deaths due to main disease progression.


Maxim Belotserkovskiy, MD

Latest:

Interexpert Agreement on Adverse Events’ Evaluation

Study measures the differing judgment levels between clinical investigators and drug safety experts.


Margarita Mare, MD

Latest:

Death Waivers an Incomplete Picture of Drug Safety

Examining the practical significance of reporting patient deaths due to main disease progression.


Jane Baxendale

Latest:

Eyes Play a Focal Role in Research

Two unique techniques help characterize pharmacodynamic drug effects in healthy subjects.


Linda Bowers

Latest:

In Pursuit of Enlightenment

Knowledge is power, but power is of no value if you don't exercise it.



Lindsay McNair, MD

Latest:

Human Gene Transfer Studies: What Clinicians Should Know

This experimental technique is being studied to see whether it could treat certain health problems.


Chris Jenkins, PhD

Latest:

Human Gene Transfer Studies: What Clinicians Should Know

This experimental technique is being studied to see whether it could treat certain health problems.

© 2024 MJH Life Sciences

All rights reserved.